Dr Dylan Peter Roman, DPT | |
255 River Rd, Willington, CT 06279-1630 | |
(860) 966-2380 | |
Not Available |
Full Name | Dr Dylan Peter Roman |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation |
Location | 255 River Rd, Willington, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275141079 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 012388 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Dylan Peter Roman, DPT 255 River Rd, Willington, CT 06279-1630 Ph: (860) 966-2380 | Dr Dylan Peter Roman, DPT 255 River Rd, Willington, CT 06279-1630 Ph: (860) 966-2380 |
News Archive
UCLA scientists have discovered a potential combination treatment for glioblastoma, the deadliest form of brain cancer in adults. The three-year study led by Dr. David Nathanson, a member of UCLA's Jonsson Comprehensive Cancer Center, found that the drug combination tested in mice disrupts and exploits glucose intake, essentially cutting off the tumor's nutrients and energy supply.
Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published today (Thursday) as a Research letter in The Lancet.
The American Autoimmune Related Diseases Association, a national nonprofit health organization dedicated to increasing awareness of autoimmune diseases, today issued a white paper to educate its membership and the patient community about biosimilar medicines after a survey found most patients were generally unaware of this new category of medicines which may soon be approved in the U.S.
Scientists from the Kimmel Cancer Center at Jefferson have discovered a possible way for malignant breast tumors to be identified, without the need for a biopsy. The findings were published online ahead of print in the Journal of Nuclear Medicine.
› Verified 6 days ago